References
[1] Acquaye, J. K., Omer, A., Ganeshaguru, K., et al. (1985). Non-benign sickle cell anaemia in western Saudi Arabia. Br J Haematol, 60(1): 99-108.
[2] Rdachi, K., Kim, J., Asakura, T., Schwartz, E. (1990). Characterization of two types of fetal hemoglobin: alpha2 G gamma2 and alpha2 Agamma2. Blood, 75(10): 2070-2075.
[3] Adams, R. J., Ohene-Frempong, K., Wang, W. (2001). “Sickle cell and the brain”. Hematology Am Soc Hematol Educ Program, (1): 31-46. Doi: 10.1182/asheducation-(2001).1.31. PMID 11722977.
[4] Dams, R. J. (2007). “Big strokes in small persons”. Arch. Neurol., 64(11): 1567-74. doi:10.1001/archneur.64.11.1567. PMID 17998439.
[5] Aidoo, M., Terlouw, D. J., Kolczak, M. S., McElroy, P. D., Terkuile, F. O., Kariuki, S., Nahlen, B. L., Lal, A. A., Udhayakumar, V. (2002). “Protective effects of the sickle cell gene against malaria morbidity and mortality”. The Lancet, Apr 13, 359 (9314): 1311-2.
[6] Aldrich, T. K., Nagel, R. L. (1998). “Pulmonary Complications of Sickle Cell Disease.” In Reynolds, H. Y., Bone, R. C., Dantzker, D. R., George, R. B., Matthay, R. A. Pulmonary and Critical Care Medicine (6th Ed.). St. Louis: Mosby. (1998) pp. 1-10. ISBN 0-8151-1371-4.
[7] Al-Jam'a, A. H., Al-Dabbous, I. A., Chirala, S. K., et al. (2000). Splenic function in sickle cell anemia patients in Qatif, Saudi Arabia. Am J Hematol, 63(2): 68-73.
[8] Allison, A. C. (2009). “Genetic control of resistance to human malaria”. Current Opinion in Immunology, 21(5): 499-505. doi:10.1016/j.coi.2009.04.001. PMID 19442502.
[9] Almeida, A., Roberts, I. (2017). “Bone involvement in sickle cell disease”. Br. J. Haematol., 129(4): 482-90. doi:10.1111/j.1365-2141.2005.05476.x. PMID 15877730.
[10] Akinsheye, I., Alsultan, A., Solovieff, N., Ngo, D., Baldwin, C. T., Sebastiani, P., Chui, D. H., Steinberg, M. H. (2018). Blood 7: 118(1): 19-27. doi: 10.1182/blood-2011-03-325258. Epub 2011 Apr 13 Fetal hemoglobin in sickle cell anemia.
[11] Ahmed, S., Saleem, M., Modell, B., Petrou, M. (2002). Screening Extended Families for Genetic Hemoglobin Disorders in Pakistan. N Engl J Med., 347: 1162-8.
[12] Khair, F. M. (2019). The genetic origin of SCD in Sudan haplotype determine of homozygous patient. MD thesis: Khartoum Univ. Br. J. Haematol., 129(4): 482-90. doi:10.1111/j.1365 2141.2005.05476.x. PMID 15877730.